The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation

Oncogene. 2002 Apr 4;21(15):2376-86. doi: 10.1038/sj.onc.1205307.

Abstract

We have analysed the radiation response of a human medullary thyroid carcinoma cell line (MTT), characterized by the absence of a functional p53 protein, and the consequences of MDM2 overexpression in this process. We show that the product of the mdm2 proto-oncogene is able to sensitize MTT cells to ionizing radiation. After radiation treatment, MTT cells display histograms consistent with a G2M arrest. MTT cells expressing MDM2 (MTT-mdm2) are unable to respond to DNA damage with G2M arrest, and display a high percentage of apoptosis. MTT-mdm2 cells show high levels of E2F-1 protein, suggesting that the induction of apoptosis observed upon MDM2 overexpression could be dependent on E2F-1. This observation is further supported with assays showing that E2F-1 binding to specific DNA sequences is enhanced in MTT-mdm2 cells. Likewise, transactivation of reporter constructs exclusively dependent on E2F-1 is also elevated after transfection with MDM2. This effect can be reverted by transient transfection with p19ARF. To link the expression of E2F-1 with the induction of apoptosis, we generated clonal cell lines overexpressing E2F-1. Transfection with E2F-1 results in a low number of outgrowing colonies with reduced proliferation rates, indicating that E2F-1 is deleterious for cell growth. This negative regulation correlates with an increase in the percentage of the cell population with DNA content below 2N, suggesting that E2F-1 promotes apoptosis. Finally, overexpression of E2F-1 sensitizes MTT cells to radiation exposure. We conclude that the effects observed by MDM2 overexpression could be mediated by E2F-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Carcinoma, Medullary / genetics
  • Carcinoma, Medullary / metabolism
  • Carcinoma, Medullary / radiotherapy*
  • Cell Cycle / radiation effects
  • Cell Cycle Proteins*
  • Cell Division
  • Cell Survival / radiation effects
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA-Binding Proteins*
  • Dose-Response Relationship, Radiation
  • E2F Transcription Factors
  • E2F1 Transcription Factor
  • Humans
  • Nuclear Proteins*
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / physiology*
  • Proto-Oncogene Proteins c-mdm2
  • Radiation, Ionizing*
  • Radiation-Sensitizing Agents / metabolism*
  • Thyroid Neoplasms / genetics
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / radiotherapy*
  • Transcription Factors / metabolism
  • Transcriptional Activation
  • Transfection
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p14ARF / physiology
  • Up-Regulation

Substances

  • Cdkn2a protein, mouse
  • Cell Cycle Proteins
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA-Binding Proteins
  • E2F Transcription Factors
  • E2F1 Transcription Factor
  • E2F1 protein, human
  • MAS1 protein, human
  • Nuclear Proteins
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Radiation-Sensitizing Agents
  • Transcription Factors
  • Tumor Suppressor Protein p14ARF
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2